chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vision blurred, White blood cell count increased
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral haemorrhage, Cerebral venous sinus thrombosis, Headache, Jugular vein thrombosis, Magnetic resonance imaging
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Nausea, Platelet count, Platelet count decreased, Venogram
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Vision blurred, Vomiting
Clinical narrative: Janssen COVID-19 Vaccine EUA: patient presents to  the emergency deaprtment (ED) reporting headache (10 out of 10 pain, difficult to keep eyes open) with neck pain, blurred vision, nausea, and photophobia for two weeks prior to arrival. Patient is four month post partum and breastfeeding. Patient diagnosed with cerebral venous sinus thrombosis and intraparenchymal hemorrhage. Admitted and underwent venous sinus thrombectomy. Currently still hospitalized.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ear pain, Tinnitus
Clinical narrative: 4/19/2021;  25 days after receiving vaccine.  -Still experiencing  ear aches, tinnitus, and a developing dry cough.  -5 days after receiving the vaccine, I experienced a sudden onrush of pressure into the cranial area, giving way to the above symptoms.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Ear pain, Intracranial pressure increased, Tinnitus
Clinical narrative: 4/19/2021;  25 days after receiving vaccine.  -Still experiencing  ear aches, tinnitus, and a developing dry cough.  -5 days after receiving the vaccine, I experienced a sudden onrush of pressure into the cranial area, giving way to the above symptoms.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Patient recived Janssen COVID vaccine at alternate site, came to ED with complaints of pain and rash starting in same arm and spreading. Diagnosed with Shingles
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster, Laboratory test, Pain in extremity, Rash
Clinical narrative: Patient recived Janssen COVID vaccine at alternate site, came to ED with complaints of pain and rash starting in same arm and spreading. Diagnosed with Shingles
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Brain natriuretic peptide, Chest X-ray, Computerised tomogram abdomen, Computerised tomogram thorax
Clinical narrative: Patient presented to the ED on 4/18/2021 with one day of shortness of breath and mid-thoracic, pleuritic back pain, found to have bilateral pulmonary emboli. He was started on apixaban 10mg BID for this at this time.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Full blood count, International normalised ratio, Metabolic function test, Prothrombin time
Clinical narrative: Patient presented to the ED on 4/18/2021 with one day of shortness of breath and mid-thoracic, pleuritic back pain, found to have bilateral pulmonary emboli. He was started on apixaban 10mg BID for this at this time.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism, Troponin I, Ultrasound scan
Clinical narrative: Patient presented to the ED on 4/18/2021 with one day of shortness of breath and mid-thoracic, pleuritic back pain, found to have bilateral pulmonary emboli. He was started on apixaban 10mg BID for this at this time.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Back pain, Computerised tomogram thorax abnormal, Dyspnoea, Infarction
Clinical narrative: Patient presented to the ED on 4/18/2021 with one day of shortness of breath and mid-thoracic, pleuritic back pain, found to have bilateral pulmonary emboli. He was started on apixaban 10mg BID for this at this time.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Infection, Lung consolidation, Platelet count normal, Pleuritic pain, Pulmonary embolism
Clinical narrative: Patient presented to the ED on 4/18/2021 with one day of shortness of breath and mid-thoracic, pleuritic back pain, found to have bilateral pulmonary emboli. He was started on apixaban 10mg BID for this at this time.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Death, Thrombosis
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Anxiety, Areflexia, Blood sodium increased, Brain herniation, Cerebral haemorrhage
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral mass effect, Coma scale abnormal, Computerised tomogram head abnormal, Computerised tomogram head normal, Condition aggravated
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Headache, Migraine, Nausea, Photophobia
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Pupil fixed, Seizure, Subarachnoid haemorrhage, Unresponsive to stimuli
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Venogram normal, Vomiting
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Adverse event
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Blood fibrinogen, Blood sodium, Cerebral haemorrhage, Cerebral venous sinus thrombosis
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Coma scale, Computerised tomogram head, Fibrin D dimer, Headache, Heparin-induced thrombocytopenia test
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Hypernatraemia, International normalised ratio, Laboratory test, Loss of consciousness, Photophobia
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count, Prophylaxis of nausea and vomiting, SARS-CoV-2 test, Seizure, Thrombocytopenia
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Venogram
Clinical narrative: Patient is a 35-year-old woman with a history of migraines on preventative medications without recent abortive therapy who underwent Covid vaccination on 4/8/2021 with Johnson & Johnson.  On 4/15/2021 around 8 PM, the patient presented to  ER  with a severe frontal headache.  Patient stated that it is been going on since around 2 PM on 4/15 when she took Tylenol and marijuana candy for relief at 4 PM.  No help.  Patient had CT venogram and CT head at 10 PM on 4/15/2021 that was normal. Patient specifically noted she was worried about the J&J vaccine and an adverse reaction. She was given Toradol, Compazine, Decadron, and magnesium with a discharge on 4/16/2021 at 2 AM.  Of note her platelet count at that time was 114 consistent with the patient's description of chronic thrombocytopenia.   On 4/17/2021 at 2 AM the patient presented to  ER.  She again had an ocular headache that is different from her normal baseline migraines. This was also clearly more severe than her typical migraines.  Still had significant nausea and vomiting along with photophobia.  Dr. reviewed Spectrum results including labs and imaging.  She again received morphine, Toradol, Reglan, Benadryl, dexamethasone.  She was discharged at 6 AM feeling a little bit better.  On 4/17/2021 at 10:30 PM the patient had an acute worsening of her headache.  At 11:30 PM on 4/17/2021 her husband found her unresponsive and called EMS.  The patient presented to emergency room at 1:30 AM on 4/18/2021 after sustaining a seizure in route and was subsequently intubated on arrival.  She had a GCS of 1 with fixed pupils and no gag reflex.  CT head was performed which revealed significant subarachnoid hemorrhage, intraparenchymal hemorrhage, with profound brainstem herniation.  Additionally, there was increased density within the right transverse and sagittal sinus questionably within the sagittal sinus that may reflect a dural venous sinus thrombosis.  Neurology and neurosurgery evaluated the patient around 3 AM in person.  Independently, imaging and clinical presentation was deemed to be incompatible with life.  Because of the sedating medications required for intubation and subsequently her sodium rising to 170, the brain death physical examination by neurology was not performed.  Repeat imaging has not yet been performed because it was deemed to be futile.  Case discussed by two Dr.'s  with  on 4/18/2021.  The VAERS report was confirmed to be submitted by both Dr's recommended sending a platelet factor 4 antibody assay.  On the morning of 4/19/2021 case was again reviewed by several Dr.'s. Discussed need for repeat imaging to better evaluate CNS vasculature. Neurology will discuss with family and ICU team to proceed with imaging.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Injection site pain
Clinical narrative: I have facial numbness on left side of my face.  I cannot move my left eye freely, and left side of my lips freely.  I cannot close or open my left eye, and left side of my lips are droopy.
Age: 50.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Facial paralysis, Hypoaesthesia, Mobility decreased
Clinical narrative: I have facial numbness on left side of my face.  I cannot move my left eye freely, and left side of my lips freely.  I cannot close or open my left eye, and left side of my lips are droopy.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dizziness, Leukocytosis, Tachycardia
Clinical narrative: Pt received his 1st Moderna covid 19 vaccine on 4/17/2021 at 3pm and around 1 am on 4/28/2021 pt began to experience sudden severe diarrhea, tachycardia and chest pain. He came into the ER and was found to have sirs, tachycardia and admitted. Pt's diarrhea improved during his hospital stay but he remain with sinus tachycardia on discharge which is new. His echocardiogram is pending. He will need follow up with his pcp and possibly cardiology. He will be taken out of work for now. Pt tested positive for covid 19 in feb 2021 and had no symptoms from covid 19.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Computerised tomogram thorax abnormal, Diarrhoea, Echocardiogram, Electrocardiogram abnormal
Clinical narrative: Pt received his 1st Moderna covid 19 vaccine on 4/17/2021 at 3pm and around 1 am on 4/28/2021 pt began to experience sudden severe diarrhea, tachycardia and chest pain. He came into the ER and was found to have sirs, tachycardia and admitted. Pt's diarrhea improved during his hospital stay but he remain with sinus tachycardia on discharge which is new. His echocardiogram is pending. He will need follow up with his pcp and possibly cardiology. He will be taken out of work for now. Pt tested positive for covid 19 in feb 2021 and had no symptoms from covid 19.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hiatus hernia, Lymph nodes scan abnormal, Lymphadenopathy, Lymphopenia, Metabolic function test normal
Clinical narrative: Pt received his 1st Moderna covid 19 vaccine on 4/17/2021 at 3pm and around 1 am on 4/28/2021 pt began to experience sudden severe diarrhea, tachycardia and chest pain. He came into the ER and was found to have sirs, tachycardia and admitted. Pt's diarrhea improved during his hospital stay but he remain with sinus tachycardia on discharge which is new. His echocardiogram is pending. He will need follow up with his pcp and possibly cardiology. He will be taken out of work for now. Pt tested positive for covid 19 in feb 2021 and had no symptoms from covid 19.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neutrophil percentage increased, Pleural thickening, SARS-CoV-2 test negative, Sinus tachycardia, Systemic inflammatory response syndrome
Clinical narrative: Pt received his 1st Moderna covid 19 vaccine on 4/17/2021 at 3pm and around 1 am on 4/28/2021 pt began to experience sudden severe diarrhea, tachycardia and chest pain. He came into the ER and was found to have sirs, tachycardia and admitted. Pt's diarrhea improved during his hospital stay but he remain with sinus tachycardia on discharge which is new. His echocardiogram is pending. He will need follow up with his pcp and possibly cardiology. He will be taken out of work for now. Pt tested positive for covid 19 in feb 2021 and had no symptoms from covid 19.
Age: 43.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tachycardia, White blood cell count increased
Clinical narrative: Pt received his 1st Moderna covid 19 vaccine on 4/17/2021 at 3pm and around 1 am on 4/28/2021 pt began to experience sudden severe diarrhea, tachycardia and chest pain. He came into the ER and was found to have sirs, tachycardia and admitted. Pt's diarrhea improved during his hospital stay but he remain with sinus tachycardia on discharge which is new. His echocardiogram is pending. He will need follow up with his pcp and possibly cardiology. He will be taken out of work for now. Pt tested positive for covid 19 in feb 2021 and had no symptoms from covid 19.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: tinnitus occurred 04/18/2021
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Dizziness, Injection site pain, Lymphadenopathy
Clinical narrative: 7 hours after shot, felt pain at injection site and slight weakness. 8 hours after shot, experienced significant muscle aches and pains in upper torso - both shoulders, upper and mid back, and neck. Shooting / pins and needle-like pains randomly down both legs and in hands. Pain in my big toe where I have a pin from a previous surgery. Day after (day 2) I woke up with all the pain gone, except for some minor injection site pain. Day 3, I started to feel dizzy, like I would fall over, in the late afternoon. That went away after about an  hour, but then I continued to experience nausea and a slight feeling of swaying  That persisted into Day 4 and Day 5. Also experienced a swollen lymph node in my neck on the opposite side of my body Day 4 and 5. On day 5 now.